116 related articles for article (PubMed ID: 94593)
1. Mouse mammary tumor virus (MMTV) antigen(s) are present on B lymphocytes of BALB/c mice.
Charyulu V; Sigel MM; Durden DL; Lopez DM
Int J Cancer; 1979 Dec; 24(6):813-8. PubMed ID: 94593
[TBL] [Abstract][Full Text] [Related]
2. B cell subsets in spleens of BALB/c mice: identification and isolation of MMTV-expressing and MMTV-responding subpopulations.
Lopez DM; Charyulu V; Paul RD
J Immunol; 1985 Jan; 134(1):603-7. PubMed ID: 2981095
[TBL] [Abstract][Full Text] [Related]
3. Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.
Lopez DM; Charyulu V; Sigel MM
Cancer Res; 1981 Mar; 41(3):813-8. PubMed ID: 6257384
[TBL] [Abstract][Full Text] [Related]
4. Emergence of a B lymphocyte population with ADCC effector function in mammary tumor bearing mice.
Padmanabhan RR; Paul RD; Watson GA; Lopez DM
J Leukoc Biol; 1988 Jun; 43(6):509-19. PubMed ID: 3259973
[TBL] [Abstract][Full Text] [Related]
5. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
[TBL] [Abstract][Full Text] [Related]
6. An antigen cross-reactive with gp52 of mammary tumor virus is expressed on a B cell subpopulation of mice.
Tax A; Ewert D; Manson LA
J Immunol; 1983 May; 130(5):2368-71. PubMed ID: 6300244
[TBL] [Abstract][Full Text] [Related]
7. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
Lopez DM; Lopez PF; Parks WP; Paul RD
J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
[TBL] [Abstract][Full Text] [Related]
8. Detection of retroviral superantigen and products of the envelope gene from endogenous mouse mammary tumor virus in B cells from BALB/c mice.
Lopez-Cepero M; Wang Y; Keydar I; Brandt-Carlson C; Butel JS; Lopez DM
Cell Immunol; 1995 Jul; 163(2):191-7. PubMed ID: 7606792
[TBL] [Abstract][Full Text] [Related]
9. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
[TBL] [Abstract][Full Text] [Related]
10. Modulation of mouse mammary tumor virus production in the MJY-alpha cell line.
Yagi MJ; Blair PB; Lane MA
J Virol; 1978 Nov; 28(2):611-23. PubMed ID: 214582
[TBL] [Abstract][Full Text] [Related]
11. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
12. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen.
Modlin CS; Muruve NA; Stanko D; Caulfield MJ; Fairchild RL
Cell Immunol; 1996 May; 169(2):252-63. PubMed ID: 8620553
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of mouse mammary tumor virus cell surface antigens: estimation of antigen abundance by protein A assay.
Callis AH; Ritzi EM
J Virol; 1980 Sep; 35(3):876-87. PubMed ID: 6252344
[TBL] [Abstract][Full Text] [Related]
14. Induction of germinal centers by MMTV encoded superantigen on B cells.
Simmons WJ; Simms M; Chiarle R; Mackay F; Tsiagbe VK; Browning J; Inghirami G; Thorbecke GJ
Dev Immunol; 2001; 8(3-4):201-11. PubMed ID: 11785670
[TBL] [Abstract][Full Text] [Related]
15. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
16. Immunoelectron microscopic studies of antibodies in mouse sera directed against mouse mammary tumor virus.
Miller MF; Dmochowski L; Bowen JM
Cancer Res; 1977 Jul; 37(7 Pt 1):2086-91. PubMed ID: 193633
[TBL] [Abstract][Full Text] [Related]
17. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
Palmer LD; Saha B; Hodes RJ; Abe R
J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
[TBL] [Abstract][Full Text] [Related]
18. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
Modlin CS; Todd GT; Cohen TD; Fairchild RL
Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
[TBL] [Abstract][Full Text] [Related]
19. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
Ritzi EM; Smith BA; Stolfi RL; Martin DS
Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
